In order to explore the regulatory mechanisms that ILF2 and ILF3 may participate in the metabolic disorders of ESCC tissues, we examined the expressed levels of these two proteins in ESCC tissues and paired para-cancer tissues. The gene discussed is ILF3; the disease is metabolic disease.